Funding Opportunities

Harvard University Funding Portal

Funding opportunities available exclusively to the Harvard community.

Sympathetic tone dictates the impact of lipolysis on FABP4 secretion

Recent work by MET researchers demonstrates that secretion of FABP4 from adipocytes can be induced through sympathetic signaling
Unlocking cellular secrets to better treat diseases

Sophie Lockwood, PhD ’23, uncovered a complex biological mechanism that could potentially help in drug development
Mitochondrial morphology controls fatty acid utilization

Publication from the Danial and Shirihai Labs reported that fatty acid utilization is selectively coupled to mitochondrial morphology.
Dr. Marie Sabatier has received an Institut Servier fellowship

Dr. Sabatier is investigating the heterogeneity of cancer cell lipid usage and its impact on metastatic potential.
mTORC1 regulates lysosome-dependent adaptive shift in intracellular lipid specie

mTORC1 in regulating the balance of intracellular lipid species between membrane phospholipids
Reciprocal effects of mTOR inhibitors on pro-survival proteins

New study from Manning Lab reveals a therapeutic strategy that combines rapamycin, which many patients are currently taking, with a BCL-2/BCL-XL

Sympathetic tone dictates the impact of lipolysis on FABP4 secretion

Recent work by MET researchers demonstrates that secretion of FABP4 from adipocytes can be induced through sympathetic signaling
Unlocking cellular secrets to better treat diseases

Sophie Lockwood, PhD ’23, uncovered a complex biological mechanism that could potentially help in drug development
Mitochondrial morphology controls fatty acid utilization

Publication from the Danial and Shirihai Labs reported that fatty acid utilization is selectively coupled to mitochondrial morphology.
Dr. Marie Sabatier has received an Institut Servier fellowship

Dr. Sabatier is investigating the heterogeneity of cancer cell lipid usage and its impact on metastatic potential.
mTORC1 regulates lysosome-dependent adaptive shift in intracellular lipid specie

mTORC1 in regulating the balance of intracellular lipid species between membrane phospholipids
Reciprocal effects of mTOR inhibitors on pro-survival proteins

New study from Manning Lab reveals a therapeutic strategy that combines rapamycin, which many patients are currently taking, with a BCL-2/BCL-XL